Join
Apollo Endosurgery Inc. logo

APEN

NASDAQ

Apollo Endosurgery Inc.

SectorHealth CareIndustryIndustrial Specialties
$9.99+0.07 (+0.71%)
News25/Ratings6

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to place full thickness sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, and delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands; and Orbera Coach, a digital and remotely delivered aftercare program. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Brazil, Australia, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.

Latest news

25 items

APEN FAQ

6 questions
  • What does Apollo Endosurgery Inc. do?
    Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to place full thickness sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, and delays gastric content emptying under the Orbera Intragastric Balloon...
  • Where does APEN stock trade?
    Apollo Endosurgery Inc. (APEN) is listed on NASDAQ.
  • What sector and industry is APEN in?
    Apollo Endosurgery Inc. operates in the Health Care sector, Industrial Specialties industry.
  • What are analysts saying about APEN?
    Apollo Endosurgery Inc. has had 6 recent analyst actions on file. The most recent action was from Stifel: Hold with a $1000.00 price target on 2023-01-04. Recent price targets range from $1000.00 to $1500.00.
  • What companies are similar to APEN?
    Notable peers in the same industry include ISRG (Intuitive Surgical Inc.), EW (Edwards Lifesciences Corporation), STE (STERIS plc (Ireland)), ZBH (Zimmer Biomet Holdings Inc.), MAS (Masco Corporation). Compare APEN side-by-side with any of them on Quantisnow.
  • How can I track APEN on Quantisnow?
    Quantisnow aggregates Apollo Endosurgery Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow APEN to receive live email and push alerts on every new disclosure.